{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:55:41Z","timestamp":1783544141198,"version":"3.55.0"},"publisher-location":"Singapore","reference-count":152,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811399121","type":"print"},{"value":"9789811399138","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-9913-8_14","type":"book-chapter","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T09:04:46Z","timestamp":1570093486000},"page":"355-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Astrocytes in Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Michelle","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","volume":"322","author":"RL Albin","year":"1990","unstructured":"Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington\u2019s disease. N Engl J Med 322:1293\u20131298","journal-title":"N Engl J Med"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0301-0082(99)00032-5","volume":"60","author":"T Alexi","year":"2000","unstructured":"Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 60:409\u2013470","journal-title":"Prog Neurobiol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4:398\u2013403","journal-title":"Nat Genet"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1139\/y99-076","volume":"77","author":"A Araque","year":"1999","unstructured":"Araque A, Sanzgiri RP, Parpura V, Haydon PG (1999) Astrocyte-induced modulation of synaptic transmission. Can J Physiol Pharmacol 77:699\u2013706","journal-title":"Can J Physiol Pharmacol"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10571-011-9725-y","volume":"31","author":"L Arregui","year":"2011","unstructured":"Arregui L, Benitez JA, Razgado LF, Vergara P, Segovia J (2011) Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington\u2019s disease delays the onset of the motor phenotype. Cell Mol Neurobiol 31:1229\u20131243","journal-title":"Cell Mol Neurobiol"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","volume":"56","author":"T Arzberger","year":"1997","unstructured":"Arzberger T, Krampfl K, Leimgruber S, Weindl A (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s disease\u2013an in situ hybridization study. J Neuropathol Exp Neurol 56:440\u2013454","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","volume":"15","author":"EH Aylward","year":"2000","unstructured":"Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, Barta PE, Pearlson GD, Ross CA (2000) Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington\u2019s disease. Mov Disord 15:552\u2013560","journal-title":"Mov Disord"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250\u20134258","journal-title":"J Neurosci"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0197-4580(94)90132-5","volume":"15","author":"MF Beal","year":"1994","unstructured":"Beal MF (1994) Huntington\u2019s disease, energy, and excitotoxicity. Neurobiol Aging 15:275\u2013276","journal-title":"Neurobiol Aging"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","volume":"11","author":"MF Beal","year":"1991","unstructured":"Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease. J Neurosci 11:1649\u20131659","journal-title":"J Neurosci"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125:1908\u20131922","journal-title":"Brain"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/glia.20798","volume":"57","author":"M Bellesi","year":"2009","unstructured":"Bellesi M, Melone M, Gubbini A, Battistacci S, Conti F (2009) GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats. Glia 57:703\u2013713","journal-title":"Glia"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.1992.263.1.C1","volume":"263","author":"EN Benveniste","year":"1992","unstructured":"Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263:C1\u201316","journal-title":"Am J Physiol"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"30178","DOI":"10.1074\/jbc.272.48.30178","volume":"272","author":"I Bjorkhem","year":"1997","unstructured":"Bjorkhem I, Lutjohann D, Breuer O, Sakinis A, Wennmalm A (1997) Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem 272:30178\u201330184","journal-title":"J Biol Chem"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1523\/JNEUROSCI.20-21-08012.2000","volume":"20","author":"O Blondel","year":"2000","unstructured":"Blondel O, Collin C, McCarran WJ, Zhu S, Zamostiano R, Gozes I, Brenneman DE, McKay RD (2000) A glia-derived signal regulating neuronal differentiation. J Neurosci 20:8012\u20138020","journal-title":"J Neurosci"},{"issue":"Pt 4","key":"14_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1469-7580.2000.19640527.x","volume":"196","author":"JP Bolam","year":"2000","unstructured":"Bolam JP, Hanley JJ, Booth PA, Bevan MD (2000) Synaptic organisation of the basal ganglia. J Anat 196(Pt 4):527\u2013542","journal-title":"J Anat"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 106:22480\u201322485","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 285:10653\u201310661","journal-title":"J Biol Chem"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/hmg\/ddn206","volume":"17","author":"TB Brown","year":"2008","unstructured":"Brown TB, Bogush AI, Ehrlich ME (2008) Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse. Hum Mol Genet 17:3095\u20133104","journal-title":"Hum Mol Genet"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/dvg.20287","volume":"45","author":"KB Casper","year":"2007","unstructured":"Casper KB, Jones K, McCarthy KD (2007) Characterization of astrocyte-specific conditional knockouts. Genesis 45:292\u2013299","journal-title":"Genesis"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2202-15-36","volume":"15","author":"AW Chan","year":"2014","unstructured":"Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K et al (2014) A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci 15:36","journal-title":"BMC Neurosci"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/aps.2011.162","volume":"33","author":"LL Chen","year":"2012","unstructured":"Chen LL, Wu JC, Wang LH, Wang J, Qin ZH, Difiglia M, Lin F (2012) Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes. Acta Pharmacol Sin 33:385\u2013392","journal-title":"Acta Pharmacol Sin"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nbd.2012.10.015","volume":"50","author":"P Conforti","year":"2013","unstructured":"Conforti P, Camnasio S, Mutti C, Valenza M, Thompson M, Fossale E, Zeitlin S, MacDonald ME, Zuccato C, Cattaneo E (2013) Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death. Neurobiol Dis 50:160\u2013170","journal-title":"Neurobiol Dis"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"Consortium, G.M.o.H.D.G.-H","year":"2015","unstructured":"Consortium, G.M.O.H.D.G.-H (2015) Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162:516\u2013526","journal-title":"Cell"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689\u2013695","journal-title":"Science"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/263244a0","volume":"263","author":"JT Coyle","year":"1976","unstructured":"Coyle JT, Schwarcz R (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington\u2019s chorea. Nature 263:244\u2013246","journal-title":"Nature"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0304-3940(86)90397-6","volume":"67","author":"AJ Cross","year":"1986","unstructured":"Cross AJ, Slater P, Reynolds GP (1986) Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington\u2019s disease. Neurosci Lett 67:198\u2013202","journal-title":"Neurosci Lett"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1042\/AN20100007","volume":"2","author":"DM Cummings","year":"2010","unstructured":"Cummings DM, Cepeda C, Levine MS (2010) Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington\u2019s disease. ASN Neuro 2:e00036","journal-title":"ASN Neuro"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","volume":"115","author":"D Toro del","year":"2010","unstructured":"del Toro D, Xifro X, Pol A, Humbert S, Saudou F, Canals JM, Alberch J (2010) Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease. J Neurochem 115:153\u2013167","journal-title":"J Neurochem"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375\u20131397","journal-title":"J Lipid Res"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4:387\u2013392","journal-title":"Nat Genet"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1523\/JNEUROSCI.0316-16.2016","volume":"36","author":"A Dvorzhak","year":"2016","unstructured":"Dvorzhak A, Vagner T, Kirmse K, Grantyn R (2016) Functional indicators of glutamate transport in single striatal astrocytes and the influence of Kir4.1 in normal and Huntington mice. J Neurosci 36:4959\u20134975","journal-title":"J Neurosci"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","volume":"34","author":"AM Estrada-Sanchez","year":"2009","unstructured":"Estrada-Sanchez AM, Montiel T, Segovia J, Massieu L (2009) Glutamate toxicity in the striatum of the R6\/2 Huntington\u2019s disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 34:78\u201386","journal-title":"Neurobiol Dis"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P et al (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum Mol Genet 19:3053\u20133067","journal-title":"Hum Mol Genet"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fncom.2012.00065","volume":"6","author":"T Fellin","year":"2012","unstructured":"Fellin T, Ellenbogen JM, De Pitta M, Ben-Jacob E, Halassa MM (2012) Astrocyte regulation of sleep circuits: experimental and modeling perspectives. Front Comput Neurosci 6:65","journal-title":"Front Comput Neurosci"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuron.2004.08.011","volume":"43","author":"T Fellin","year":"2004","unstructured":"Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G (2004) Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43:729\u2013743","journal-title":"Neuron"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/exnr.1993.1006","volume":"119","author":"RJ Ferrante","year":"1993","unstructured":"Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF (1993) Excitotoxin lesions in primates as a model for Huntington\u2019s disease: histopathologic and neurochemical characterization. Exp Neurol 119:46\u201371","journal-title":"Exp Neurol"},{"key":"14_CR43","first-page":"29","volume":"27","author":"F Fonnum","year":"1981","unstructured":"Fonnum F, Soreide A, Kvale I, Walker J, Walaas I (1981) Glutamate in cortical fibers. Adv Biochem Psychopharmacol 27:29\u201341","journal-title":"Adv Biochem Psychopharmacol"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0306-4522(81)90168-8","volume":"6","author":"F Fonnum","year":"1981","unstructured":"Fonnum F, Storm-Mathisen J, Divac I (1981) Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience 6:863\u2013873","journal-title":"Neuroscience"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.1523\/JNEUROSCI.2532-06.2006","volume":"26","author":"YM Ganat","year":"2006","unstructured":"Ganat YM, Silbereis J, Cave C, Ngu H, Anderson GM, Ohkubo Y, Ment LR, Vaccarino FM (2006) Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J Neurosci 26:8609\u20138621","journal-title":"J Neurosci"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","volume":"49","author":"E Gomez-Tortosa","year":"2001","unstructured":"Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP et al (2001) Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol 49:29\u201334","journal-title":"Ann Neurol"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/hmg\/ddy375","volume":"28","author":"R Goold","year":"2019","unstructured":"Goold R, Flower M, Moss DH, Medway C, Wood-Kaczmar A, Andre R, Farshim P, Bates GP, Holmans P, Jones L et al (2019) FAN1 modifies Huntington\u2019s disease progression by stabilizing the expanded HTT CAG repeat. Hum Mol Genet 28:650\u2013661","journal-title":"Hum Mol Genet"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","volume":"29","author":"RK Graham","year":"2009","unstructured":"Graham RK, Pouladi MA, Joshi P, Lu G, Deng Y, Wu NP, Figueroa BE, Metzler M, Andre VM, Slow EJ et al (2009) Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. J Neurosci 29:2193\u20132204","journal-title":"J Neurosci"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE et al (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","volume":"13","author":"AM Graybiel","year":"1990","unstructured":"Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244\u2013254","journal-title":"Trends Neurosci"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Group, T.H.s.D.C.R","year":"1993","unstructured":"Group, T.H.s.D.C.R (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-2-8","volume":"2","author":"X Gu","year":"2007","unstructured":"Gu X, Andre VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW (2007) Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington\u2019s disease. Mol Neurodegener 2:8","journal-title":"Mol Neurodegener"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I et al (2005) Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433\u2013444","journal-title":"Neuron"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci Off J Soc Neurosci 19:2522\u20132534","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1006\/exnr.1998.6919","volume":"154","author":"GM Halliday","year":"1998","unstructured":"Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E (1998) Regional specificity of brain atrophy in Huntington\u2019s disease. Exp Neurol 154:663\u2013672","journal-title":"Exp Neurol"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","volume":"133","author":"JC Hedreen","year":"1991","unstructured":"Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease. Neurosci Lett 133:257\u2013261","journal-title":"Neurosci Lett"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N","volume":"57","author":"L Hertz","year":"1999","unstructured":"Hertz L, Dringen R, Schousboe A, Robinson SR (1999) Astrocytes: glutamate producers for neurons. J Neurosci Res 57:417\u2013428","journal-title":"J Neurosci Res"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1017\/S1355617707070671","volume":"13","author":"SC Hinton","year":"2007","unstructured":"Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM (2007) Motor timing variability increases in preclinical Huntington\u2019s disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13:539\u2013543","journal-title":"J Int Neuropsychol Soc"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J et al (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","volume":"36","author":"Y Hong","year":"2016","unstructured":"Hong Y, Zhao T, Li XJ, Li S (2016) Mutant Huntingtin impairs BDNF release from astrocytes by disrupting conversion of Rab3a-GTP into Rab3a-GDP. J Neurosci 36:8790\u20138801","journal-title":"J Neurosci"},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jnr.20061","volume":"76","author":"X Hua","year":"2004","unstructured":"Hua X, Malarkey EB, Sunjara V, Rosenwald SE, Li WH, Parpura V (2004) C(a2+)-dependent glutamate release involves two classes of endoplasmic reticulum Ca(2+) stores in astrocytes. J Neurosci Res 76:86\u201397","journal-title":"J Neurosci Res"},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","volume":"40","author":"K Huang","year":"2010","unstructured":"Huang K, Kang MH, Askew C, Kang R, Sanders SS, Wan J, Davis NG, Hayden MR (2010) Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol Dis 40:207\u2013215","journal-title":"Neurobiol Dis"},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1176\/jnp.15.1.109","volume":"15","author":"G Huntington","year":"2003","unstructured":"Huntington G (2003) On chorea. George Huntington, M.D. J Neuropsychiatry Clin Neurosci 15:109\u2013112","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.23050","volume":"65","author":"AH Jansen","year":"2017","unstructured":"Jansen AH, van Hal M, Op den Kelder IC, Meier RT, de Ruiter AA, Schut MH, Smith DL, Grit C, Brouwer N, Kamphuis W et al (2017) Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. Glia 65:50\u201361","journal-title":"Glia"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","volume":"36","author":"R Jiang","year":"2016","unstructured":"Jiang R, Diaz-Castro B, Looger LL, Khakh BS (2016) Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington\u2019s disease model mice. J Neurosci 36:3453\u20133470","journal-title":"J Neurosci"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","volume":"29","author":"PR Joshi","year":"2009","unstructured":"Joshi PR, Wu NP, Andre VM, Cummings DM, Cepeda C, Joyce JA, Carroll JB, Leavitt BR, Hayden MR, Levine MS et al (2009) Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci 29:2414\u20132427","journal-title":"J Neurosci"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07605","volume":"456","author":"R Kang","year":"2008","unstructured":"Kang R, Wan J, Arstikaitis P, Takahashi H, Huang K, Bailey AO, Thompson JX, Roth AF, Drisdel RC, Mastro R et al (2008) Neural palmitoyl-proteomics reveals dynamic synaptic palmitoylation. Nature 456:904\u2013909","journal-title":"Nature"},{"key":"14_CR69","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1084\/jem.189.5.865","volume":"189","author":"M Kerschensteiner","year":"1999","unstructured":"Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I et al (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865\u2013870","journal-title":"J Exp Med"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","volume":"132","author":"HP Kremer","year":"1991","unstructured":"Kremer HP, Roos RA, Dingjan GM, Bots GT, Bruyn GW, Hofman MA (1991) The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease. Neurosci Lett 132:101\u2013104","journal-title":"Neurosci Lett"},{"key":"14_CR71","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/s41598-019-40165-w","volume":"9","author":"SB Lallani","year":"2019","unstructured":"Lallani SB, Villalba RM, Chen Y, Smith Y, Chan AWS (2019) Striatal interneurons in transgenic nonhuman primate model of Huntington\u2019s Disease. Sci Rep 9:3528","journal-title":"Sci Rep"},{"key":"14_CR72","doi-asserted-by":"crossref","unstructured":"Landwehrmeyer GB, McNeil SM, Dure LSt, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E et al (1995) Huntington\u2019s disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218\u2013230","DOI":"10.1002\/ana.410370213"},{"key":"14_CR73","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","volume":"26","author":"JM Lee","year":"2017","unstructured":"Lee JM, Chao MJ, Harold D, Abu Elneel K, Gillis T, Holmans P, Jones L, Orth M, Myers RH, Kwak S et al (2017) A modifier of Huntington\u2019s disease onset at the MLH1 locus. Hum Mol Genet 26:3859\u20133867","journal-title":"Hum Mol Genet"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nbd.2013.06.002","volume":"58C","author":"W Lee","year":"2013","unstructured":"Lee W, Reyes RC, Gottipati MK, Lewis K, Lesort M, Parpura V, Gray M (2013) Enhanced Ca-dependent glutamate release from astrocytes of the BACHD Huntington\u2019s disease mouse model. Neurobiol Dis 58C:192\u2013199","journal-title":"Neurobiol Dis"},{"key":"14_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","volume":"494","author":"V Leoni","year":"2011","unstructured":"Leoni V, Mariotti C, Nanetti L, Salvatore E, Squitieri F, Bentivoglio AR, Bandettini di Poggio M, Piacentini S, Monza D, Valenza M et al (2011) Whole body cholesterol metabolism is impaired in Huntington\u2019s disease. Neurosci Lett 494:245\u2013249","journal-title":"Neurosci Lett"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Bjorkhem I et al (2008) Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain 131:2851\u20132859","journal-title":"Brain"},{"key":"14_CR77","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/378133","volume":"73","author":"JL Li","year":"2003","unstructured":"Li JL, Hayden MR, Almqvist EW, Brinkman RR, Durr A, Dode C, Morrison PJ, Suchowersky O, Ross CA, Margolis RL et al (2003) A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet 73:682\u2013687","journal-title":"Am J Hum Genet"},{"key":"14_CR78","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1471-4159.2004.02420.x","volume":"89","author":"CM Liberto","year":"2004","unstructured":"Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW (2004) Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89:1092\u20131100","journal-title":"J Neurochem"},{"key":"14_CR79","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Lievens","year":"2001","unstructured":"Lievens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L, Bates GP (2001) Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice. Neurobiol Dis 8:807\u2013821","journal-title":"Neurobiol Dis"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"14_CR81","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/brain\/awq179","volume":"133","author":"RA Linker","year":"2010","unstructured":"Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Luhder F et al (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133:2248\u20132263","journal-title":"Brain"},{"key":"14_CR82","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nn.3080","volume":"15","author":"V Lo Sardo","year":"2012","unstructured":"Lo Sardo V, Zuccato C, Gaudenzi G, Vitali B, Ramos C, Tartari M, Myre MA, Walker JA, Pistocchi A, Conti L et al (2012) An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat Neurosci 15:713\u2013721","journal-title":"Nat Neurosci"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","volume":"96","author":"EG Lund","year":"1999","unstructured":"Lund EG, Guileyardo JM, Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 96:7238\u20137243","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR84","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR et al (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133\u2013140","journal-title":"Nat Neurosci"},{"key":"14_CR85","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"14_CR86","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/archneur.58.3.365","volume":"58","author":"NJ Maragakis","year":"2001","unstructured":"Maragakis NJ, Rothstein JD (2001) Glutamate transporters in neurologic disease. Arch Neurol 58:365\u2013370","journal-title":"Arch Neurol"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/263517a0","volume":"263","author":"EG McGeer","year":"1976","unstructured":"McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids. Nature 263:517\u2013519","journal-title":"Nature"},{"key":"14_CR88","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K et al (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7:e49838","journal-title":"PLoS ONE"},{"key":"14_CR89","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/glia.23022","volume":"64","author":"C Meunier","year":"2016","unstructured":"Meunier C, Merienne N, Jolle C, Deglon N, Pellerin L (2016) Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington\u2019s disease. Glia 64:1841\u20131856","journal-title":"Glia"},{"key":"14_CR90","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse. Neuroscience 153:329\u2013337","journal-title":"Neuroscience"},{"key":"14_CR91","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","volume":"585","author":"AJ Milnerwood","year":"2007","unstructured":"Milnerwood AJ, Raymond LA (2007) Corticostriatal synaptic function in mouse models of Huntington\u2019s disease: early effects of huntingtin repeat length and protein load. J Physiol 585:817\u2013831","journal-title":"J Physiol"},{"key":"14_CR92","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1523\/JNEUROSCI.1592-15.2015","volume":"35","author":"N Miyamoto","year":"2015","unstructured":"Miyamoto N, Maki T, Shindo A, Liang AC, Maeda M, Egawa N, Itoh K, Lo EK, Lok J, Ihara M et al (2015) Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor. J Neurosci 35:14002\u201314008","journal-title":"J Neurosci"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1523\/JNEUROSCI.3770-03.2004","volume":"24","author":"V Montana","year":"2004","unstructured":"Montana V, Ni Y, Sunjara V, Hua X, Parpura V (2004) Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci Off J Soc Neurosci 24:2633\u20132642","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"14_CR94","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31:21\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.expneurol.2012.10.014","volume":"243","author":"AJ Morton","year":"2013","unstructured":"Morton AJ (2013) Circadian and sleep disorder in Huntington\u2019s disease. Exp Neurol 243:34\u201344","journal-title":"Exp Neurol"},{"key":"14_CR96","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1113\/jphysiol.2009.177881","volume":"587","author":"A Omrani","year":"2009","unstructured":"Omrani A, Melone M, Bellesi M, Safiulina V, Aida T, Tanaka K, Cherubini E, Conti F (2009) Up-regulation of GLT-1 severely impairs LTD at mossy fibre\u2013CA3 synapses. J Physiol 587:4575\u20134588","journal-title":"J Physiol"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1073\/pnas.97.15.8629","volume":"97","author":"V Parpura","year":"2000","unstructured":"Parpura V, Haydon PG (2000) Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci U S A 97:8629\u20138634","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0974-2","volume-title":"Pathological potential of neuroglia: possible new targets for medical intervention","author":"V Parpura","year":"2014","unstructured":"Parpura V, Verkhratski\u012d AN (2014) Pathological potential of neuroglia: possible new targets for medical intervention. Springer, New York"},{"key":"14_CR99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresrev.2009.11.008","volume":"63","author":"V Parpura","year":"2010","unstructured":"Parpura V, Zorec R (2010) Gliotransmission: exocytotic release from astrocytes. Brain Res Rev 63:83\u201392","journal-title":"Brain Res Rev"},{"key":"14_CR100","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/ejn.12202","volume":"38","author":"GT Petr","year":"2013","unstructured":"Petr GT, Schultheis LA, Hussey KC, Sun Y, Dubinsky JM, Aoki C, Rosenberg PA (2013) Decreased expression of GLT-1 in the R6\/2 model of Huntington\u2019s disease does not worsen disease progression. Eur J Neurosci 38:2477\u20132490","journal-title":"Eur J Neurosci"},{"key":"14_CR101","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0005-2736(03)00024-5","volume":"1610","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610:271\u2013280","journal-title":"Biochim Biophys Acta"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1194\/jlr.R009548","volume":"52","author":"FD Porter","year":"2011","unstructured":"Porter FD, Herman GE (2011) Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 52:6\u201334","journal-title":"J Lipid Res"},{"key":"14_CR103","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27:1083\u20131091","journal-title":"Mov Disord"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1136\/jmg.2006.045120","volume":"44","author":"OW Quarrell","year":"2007","unstructured":"Quarrell OW, Rigby AS, Barron L, Crow Y, Dalton A, Dennis N, Fryer AE, Heydon F, Kinning E, Lashwood A et al (2007) Reduced penetrance alleles for Huntington\u2019s disease: a multi-centre direct observational study. J Med Genet 44:e68","journal-title":"J Med Genet"},{"key":"14_CR105","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"PH Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO Jr, Miller G, Tagle DA (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20:198\u2013202","journal-title":"Nat Genet"},{"key":"14_CR106","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.expneurol.2016.08.012","volume":"285","author":"C Reick","year":"2016","unstructured":"Reick C, Ellrichmann G, Tsai T, Lee DH, Wiese S, Gold R, Saft C, Linker RA (2016) Expression of brain-derived neurotrophic factor in astrocytes\u2014beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington\u2019s disease. Exp Neurol 285:12\u201323","journal-title":"Exp Neurol"},{"key":"14_CR107","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/MN:28:3:259","volume":"28","author":"A Reiner","year":"2003","unstructured":"Reiner A, Dragatsis I, Zeitlin S, Goldowitz D (2003) Wild-type huntingtin plays a role in brain development and neuronal survival. Mol Neurobiol 28:259\u2013276","journal-title":"Mol Neurobiol"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/mds.25624","volume":"28","author":"A Reiner","year":"2013","unstructured":"Reiner A, Shelby E, Wang H, Demarch Z, Deng Y, Guley NH, Hogg V, Roxburgh R, Tippett LJ, Waldvogel HJ et al (2013) Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia. Mov Disord 28:1691\u20131699","journal-title":"Mov Disord"},{"key":"14_CR109","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ana.410380605","volume":"38","author":"EK Richfield","year":"1995","unstructured":"Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P (1995) Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington\u2019s disease patients. Ann Neurol 38:852\u2013861","journal-title":"Ann Neurol"},{"key":"14_CR110","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","volume":"65","author":"HD Rosas","year":"2005","unstructured":"Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745\u2013747","journal-title":"Neurology"},{"key":"14_CR111","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"14_CR112","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ, Chotai K, Connarty M, Crauford D, Curtis A et al (1996) Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 59:16\u201322","journal-title":"Am J Hum Genet"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","volume":"105","author":"PR Sanberg","year":"1989","unstructured":"Sanberg PR, Calderon SF, Giordano M, Tew JM, Norman AB (1989) The quinolinic acid model of Huntington\u2019s disease: locomotor abnormalities. Exp Neurol 105:45\u201353","journal-title":"Exp Neurol"},{"key":"14_CR114","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1074\/jbc.270.3.1161","volume":"270","author":"HB Sanchez","year":"1995","unstructured":"Sanchez HB, Yieh L, Osborne TF (1995) Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J Biol Chem 270:1161\u20131169","journal-title":"J Biol Chem"},{"key":"14_CR115","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/hmg\/4.8.1365","volume":"4","author":"G Schilling","year":"1995","unstructured":"Schilling G, Sharp AH, Loev SJ, Wagster MV, Li SH, Stine OC, Ross CA (1995) Expression of the Huntington\u2019s disease (IT15) protein product in HD patients. Hum Mol Genet 4:1365\u20131371","journal-title":"Hum Mol Genet"},{"key":"14_CR116","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","volume":"98","author":"M Shankaran","year":"2017","unstructured":"Shankaran M, Di Paolo E, Leoni V, Caccia C, Ferrari Bardile C, Mohammed H, Di Donato S, Kwak S, Marchionini D, Turner S et al (2017) Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: a cross-validation study in Q175 knock-in mice. Neurobiol Dis 98:66\u201376","journal-title":"Neurobiol Dis"},{"key":"14_CR117","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A et al (1995) Widespread expression of Huntington\u2019s disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"14_CR118","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012","journal-title":"J Cell Biol"},{"key":"14_CR119","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/exnr.1998.6778","volume":"150","author":"SK Singhrao","year":"1998","unstructured":"Singhrao SK, Thomas P, Wood JD, MacMillan JC, Neal JW, Harper PS, Jones AL (1998) Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington\u2019s, Alzheimer\u2019s, and Pick\u2019s diseases. Exp Neurol 150:213\u2013222","journal-title":"Exp Neurol"},{"key":"14_CR120","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"14_CR121","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 4:393\u2013397","journal-title":"Nat Genet"},{"key":"14_CR122","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","volume":"45","author":"AC Solomon","year":"2007","unstructured":"Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K et al (2007) Verbal episodic memory declines prior to diagnosis in Huntington\u2019s disease. Neuropsychologia 45:1767\u20131776","journal-title":"Neuropsychologia"},{"key":"14_CR123","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/mp.2011.28","volume":"16","author":"D Soulet","year":"2011","unstructured":"Soulet D, Cicchetti F (2011) The role of immunity in Huntington\u2019s disease. Mol Psychiatry 16:889\u2013902","journal-title":"Mol Psychiatry"},{"key":"14_CR124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/brain\/awf015","volume":"125","author":"C Stadelmann","year":"2002","unstructured":"Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75\u201385","journal-title":"Brain"},{"key":"14_CR125","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791\u2013801","journal-title":"Lancet Neurol"},{"key":"14_CR126","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I, Olsen ML, Sofroniew MV et al (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat Neurosci 17:694\u2013703","journal-title":"Nat Neurosci"},{"key":"14_CR127","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","volume":"15","author":"E Trushina","year":"2006","unstructured":"Trushina E, Singh RD, Dyer RB, Cao S, Shah VH, Parton RG, Pagano RE, McMurray CT (2006) Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet 15:3578\u20133591","journal-title":"Hum Mol Genet"},{"key":"14_CR128","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)37560-X","volume":"37","author":"SD Turley","year":"1996","unstructured":"Turley SD, Burns DK, Rosenfeld CR, Dietschy JM (1996) Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J Lipid Res 37:1953\u20131961","journal-title":"J Lipid Res"},{"key":"14_CR129","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O et al (2010) Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J Neurosci 30:10844\u201310850","journal-title":"J Neurosci"},{"key":"14_CR130","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","volume":"28","author":"M Valenza","year":"2007","unstructured":"Valenza M, Leoni V, Tarditi A, Mariotti C, Bjorkhem I, Di Donato S, Cattaneo E (2007) Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 28:133\u2013142","journal-title":"Neurobiol Dis"},{"key":"14_CR131","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G, Cattaneo E (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ 22:690\u2013702","journal-title":"Cell Death Differ"},{"key":"14_CR132","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M et al (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 25:9932\u20139939","journal-title":"J Neurosci"},{"key":"14_CR133","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","volume":"258","author":"SJ Bogaard van den","year":"2011","unstructured":"van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA et al (2011) Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease. J Neurol 258:412\u2013420","journal-title":"J Neurol"},{"key":"14_CR134","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","volume":"580","author":"JE Vance","year":"2006","unstructured":"Vance JE (2006) Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett 580:5518\u20135524","journal-title":"FEBS Lett"},{"key":"14_CR135","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR136","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","volume":"89","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP, Keller C, Pilar Amaya MD (2008) Neuropathology of Huntington\u2019s Disease. Handb Clin Neurol 89:599\u2013618","journal-title":"Handb Clin Neurol"},{"key":"14_CR137","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR138","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/jnr.23965","volume":"95","author":"I Vorisek","year":"2017","unstructured":"Vorisek I, Syka M, Vargova L (2017) Brain diffusivity and structural changes in the R6\/2 mouse model of Huntington disease. J Neurosci Res 95:1474\u20131484","journal-title":"J Neurosci Res"},{"key":"14_CR139","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2012.01.077","volume":"1449","author":"L Wang","year":"2012","unstructured":"Wang L, Lin F, Wang J, Wu J, Han R, Zhu L, Difiglia M, Qin Z (2012) Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of BDNF. Brain Res 1449:69\u201382","journal-title":"Brain Res"},{"key":"14_CR140","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/abbs\/gmr125","volume":"44","author":"L Wang","year":"2012","unstructured":"Wang L, Lin F, Wang J, Wu J, Han R, Zhu L, Zhang G, DiFiglia M, Qin Z (2012) Truncated N-terminal huntingtin fragment with expanded-polyglutamine (htt552-100Q) suppresses brain-derived neurotrophic factor transcription in astrocytes. Acta Biochim Biophys Sin (Shanghai) 44:249\u2013258","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"14_CR141","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nm.3514","volume":"20","author":"N Wang","year":"2014","unstructured":"Wang N, Gray M, Lu XH, Cantle JP, Holley SM, Greiner E, Gu X, Shirasaki D, Cepeda C, Li Y et al (2014) Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease. Nat Med 20:536\u2013541","journal-title":"Nat Med"},{"key":"14_CR142","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayan J et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA 101:3498\u20133503","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR143","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0079-6123(08)62630-8","volume":"82","author":"CJ Wilson","year":"1990","unstructured":"Wilson CJ, Xu ZC, Emson PC, Feler C (1990) Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts. Prog Brain Res 82:417\u2013426","journal-title":"Prog Brain Res"},{"key":"14_CR144","first-page":"487","volume":"28","author":"TE Wood","year":"2019","unstructured":"Wood TE, Barry J, Yang Z, Cepeda C, Levine MS, Gray M (2019) Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model. Hum Mol Genet 28:487\u2013500","journal-title":"Hum Mol Genet"},{"key":"14_CR145","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J et al (2008) Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature 453:921\u2013924","journal-title":"Nature"},{"key":"14_CR146","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"ZX Yu","year":"2003","unstructured":"Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, Li XJ (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington\u2019s disease. J Neurosci 23:2193\u20132202","journal-title":"J Neurosci"},{"key":"14_CR147","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease. Neuron 33:849\u2013860","journal-title":"Neuron"},{"key":"14_CR148","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929\u201311947","journal-title":"J Neurosci"},{"key":"14_CR149","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217\u2013247","journal-title":"Annu Rev Neurosci"},{"key":"14_CR150","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"14_CR151","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E (2005) Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery. Pharmacol Res 52:133\u2013139","journal-title":"Pharmacol Res"},{"key":"14_CR152","doi-asserted-by":"publisher","first-page":"e22966","DOI":"10.1371\/journal.pone.0022966","volume":"6","author":"C Zuccato","year":"2011","unstructured":"Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A et al (2011) Brain-derived neurotrophic factor in patients with Huntington\u2019s disease. PLoS ONE 6:e22966","journal-title":"PLoS ONE"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroglia in Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-9913-8_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T21:07:59Z","timestamp":1611436079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-9913-8_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811399121","9789811399138"],"references-count":152,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-9913-8_14","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736739835.793585560","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"4 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}